Skip to Content
eLife home page
Submit my research
(via ORCID - An ORCID is a persistent digital identifier for researchers)
Browse the search results
Page 2 of 146
Early-career researcher travel grants: Latest two authors selected
To support their attendance and presentation at a meeting of their choice, each will receive a grant of up to $1,000.
June roundup of eLife papers in the news
Showcasing the top mentions that eLife papers received in June.
Innovation Leaders 2020: Introducing the cohort
We announce the participants and projects joining our new mentorship and open leadership training programme.
Special Issue: Meet the editors for aging, geroscience and longevity
Learn more about the group of expert editors reviewing articles for this Special Issue.
Annual report: Looking back on 2017
A reflection on eLife's achievements in 2017, notably in convening and supporting communities, modernising technology for research communication and partnering with early-career researchers.
Advances in Cancer Research: Authors share their research on World Cancer Day
eLife authors discuss their latest findings in brain tumours, breast, muscle and pancreatic cancer.
Special Issue: Call for papers in aging, geroscience and longevity
eLife is pleased to announce a new Special Issue, curating the very best research in this field.
March roundup of eLife papers in the news
High-profile news coverage that eLife papers generated in March 2017, including New Scientist, The New York Times and more.
Early-career researcher travel grants 2018: First seven authors selected
The eLife travel grant programme offers up to $1000 to help recipients gain exposure and recognition for their work.
Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia
Sumiko Takao et al.
Definition of leukemia gene expression mechanisms reveals general principles of cancer gene control and offers a pharmacologic strategy for its therapeutic reprogramming.
Be the first to read new articles from eLife
Sign up for alerts
Please leave this field empty
Back to top